Photosensitized degradation of losartan potassium in an extemporaneous suspension formulation.

J Pharm Biomed Anal

Pharmaceutical Research & Development, Merck Research Laboratories, P.O. Box 4, West Point, PA 19846, USA.

Published: October 2006

During development of an extemporaneous suspension formulation for losartan potassium, previously unknown degradation products were observed in experimental suspensions prepared in a commercial cherry syrup vehicle. These degradates increased rapidly when analytical solutions prepared from that suspension were exposed to ambient light. The structures of the degradates were determined using a combination of preparative HPLC, LC/MS, (13)C and (1)H NMR (1D and 2D), and mechanistic chemistry. Each degradate results from destruction of the imidazole ring of losartan. Formation of the two major degradates required exposure to light (UV or visible) and the presence of oxygen. Experiments using Rose Bengal (a singlet oxygen photosensitizer) and 1,4-diazabicyclooctane (DABCO; a singlet oxygen quencher) established that the major photodegradates are formed via the intermediacy of singlet oxygen. The identity of the photosensitizer in the formulation was not unequivocally determined; however, the experiments implicated the artificial flavoring in fulfilling this role.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2006.04.030DOI Listing

Publication Analysis

Top Keywords

singlet oxygen
12
losartan potassium
8
extemporaneous suspension
8
suspension formulation
8
photosensitized degradation
4
degradation losartan
4
potassium extemporaneous
4
formulation development
4
development extemporaneous
4
formulation losartan
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!